| Purification and characterization of the mammalian myosin light chain phosphatase holoenzyme. The differential effects of the holoenzyme and its subunits on smooth muscle. A Shirazi, K Iizuka, P Fadden, C Mosse, AP Somlyo, AV Somlyo, ... Journal of Biological Chemistry 269 (50), 31598-31606, 1994 | 243 | 1994 |
| Distinct roles of VEGFR-1 and VEGFR-2 in the aberrant hematopoiesis associated with elevated levels of VEGF Y Huang, X Chen, MM Dikov, SV Novitskiy, CA Mosse, L Yang, ... Blood, The Journal of the American Society of Hematology 110 (2), 624-631, 2007 | 240 | 2007 |
| The class I antigen-processing pathway for the membrane protein tyrosinase involves translation in the endoplasmic reticulum and processing in the cytosol CA Mosse, L Meadows, CJ Luckey, DJ Kittlesen, EL Huczko, ... The Journal of experimental medicine 187 (1), 37-48, 1998 | 170 | 1998 |
| The prognostic significance of tertiary Gleason pattern 5 in radical prostatectomy specimens CA Mosse, C Magi-Galluzzi, T Tsuzuki, JI Epstein The American journal of surgical pathology 28 (3), 394-398, 2004 | 133 | 2004 |
| Inhibition of FLT3 signaling targets DCs to ameliorate autoimmune disease KA Whartenby, PA Calabresi, E McCadden, B Nguyen, D Kardian, ... Proceedings of the National Academy of Sciences 102 (46), 16741-16746, 2005 | 131 | 2005 |
| Inhibition of FLT3 signaling targets DCs to ameliorate autoimmune disease KA Whartenby, PA Calabresi, E McCadden, B Nguyen, D Kardian, ... Proceedings of the National Academy of Sciences 102 (46), 16741-16746, 2005 | 131 | 2005 |
| Chronic lymphocytic leukemia/small lymphocytic lymphoma, version 4.2020, NCCN clinical practice guidelines in oncology WG Wierda, JC Byrd, JS Abramson, SF Bilgrami, G Bociek, D Brander, ... Journal of the National Comprehensive Cancer Network 18 (2), 185-217, 2020 | 124 | 2020 |
| T lymphocyte subset abnormalities in the blood and lung in pulmonary arterial hypertension ED Austin, MT Rock, CA Mosse, CL Vnencak-Jones, SM Yoder, ... Respiratory medicine 104 (3), 454-462, 2010 | 99 | 2010 |
| Processing of a class I-restricted epitope from tyrosinase requires peptide N-glycanase and the cooperative action of endoplasmic reticulum aminopeptidase 1 and cytosolic proteases ML Altrich-VanLith, M Ostankovitch, JM Polefrone, CA Mosse, ... The Journal of Immunology 177 (8), 5440-5450, 2006 | 72 | 2006 |
| Insulin activates a novel adipocyte mitogen-activated protein kinase kinase kinase that shows rapid phasic kinetics and is distinct from c-Raf. CM Haystead, P Gregory, A Shirazi, P Fadden, C Mosse, P Dent, ... Journal of Biological Chemistry 269 (17), 12804-12808, 1994 | 70 | 1994 |
| Kikuchi-Fujimoto lymphadenitis: role of parvovirus B-19, Epstein-Barr virus, human herpesvirus 6, and human herpesvirus 8 FGN Rosado, YW Tang, RP Hasserjian, CM McClain, B Wang, CA Mosse Human Pathology 44 (2), 255-259, 2013 | 69 | 2013 |
| NF-κB inducing kinase (NIK) modulates melanoma tumorigenesis by regulating expression of pro-survival factors through the β-catenin pathway YM Thu, Y Su, J Yang, R Splittgerber, S Na, A Boyd, C Mosse, C Simons, ... Oncogene 31 (20), 2580-2592, 2012 | 66 | 2012 |
| NCCN Guidelines® insights: chronic lymphocytic leukemia/small lymphocytic lymphoma, Version 3.2022: featured updates to the NCCN guidelines WG Wierda, J Brown, JS Abramson, F Awan, SF Bilgrami, G Bociek, ... Journal of the National Comprehensive Cancer Network 20 (6), 622-634, 2022 | 50 | 2022 |
| NCCN guidelines insights: chronic lymphocytic leukemia/small lymphocytic lymphoma, version 2.2019 WG Wierda, JC Byrd, JS Abramson, SF Bilgrami, G Bociek, D Brander, ... Journal of the National Comprehensive Cancer Network 17 (1), 12-20, 2019 | 46 | 2019 |
| Optimizing personalized bone marrow testing using an evidence-based, interdisciplinary team approach AC Seegmiller, AS Kim, CA Mosse, MA Levy, MA Thompson, MK Kressin, ... American journal of clinical pathology 140 (5), 643-650, 2013 | 39 | 2013 |
| Hairy cell leukemia, version 2.2018, NCCN clinical practice guidelines in oncology WG Wierda, JC Byrd, JS Abramson, S Bhat, G Bociek, D Brander, J Brown, ... Journal of the National Comprehensive Cancer Network 15 (11), 1414-1427, 2017 | 34 | 2017 |
| B-ALL minimal residual disease flow cytometry: an application of a novel method for optimization of a single-tube model AC Shaver, BW Greig, CA Mosse, AC Seegmiller American Journal of Clinical Pathology 143 (5), 716-724, 2015 | 33 | 2015 |
| Natural killer-cell neoplasms JP Greer, CA Mosse Current hematologic malignancy reports 4 (4), 245-252, 2009 | 33 | 2009 |
| Minimal residual disease in myeloma: are we there yet? AJ Hart, MH Jagasia, AS Kim, CA Mosse, BN Savani, A Kassim Biology of Blood and Marrow Transplantation 18 (12), 1790-1799, 2012 | 31 | 2012 |
| Clinicopathologic correlation of epidemiologic and histopathologic features of pediatric bacterial lymphadenitis FG Nunes Rosado, CW Stratton, CA Mosse Archives of pathology & laboratory medicine 135 (11), 1490-1493, 2011 | 30 | 2011 |
